Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2026 10:13 ET | Source: BCC Research LLC

AI Is Reshaping Neuroprotective Drug Discovery Market: New BCC Research Pulse Report Maps the Investment and Innovation Landscape

The neuroprotective agents market in North America is growing at approximately 4.5% CAGR through 2030, with AI-driven approaches.
March 27, 2026 10:10 ET | Source: Aclaris Therapeutics, Inc.

Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138

Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138
March 27, 2026 10:04 ET | Source: Mount Sinai Press Office

Mount Sinai and Guyana Ministry of Health Launch National Initiative to Strengthen Hospital Quality and Patient Safety

Georgetown, Guyana and New York, NY, March 27, 2026 (GLOBE NEWSWIRE) -- Mount Sinai Health System and the Guyana Ministry of Health today announced the launch of a national hospital quality...
March 27, 2026 09:15 ET | Source: Equity Insider

The U.S. Imports ~95% of Its Uranium. One of the Largest Domestic Deposits Just Engaged a Highly Experienced Permitting Team

NUCL, UUUU, UROY, BWXT, and NNE as Domestic Nuclear Supply Chains Move From Policy to Permitting Issued on behalf of Eagle Nuclear Energy Corp. Companies mentioned in this article: Eagle Nuclear...
March 27, 2026 09:00 ET | Source: AnaptysBio, Inc.

Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update

Anaptys to spin-off biopharma operations into First Tracks Biotherapeutics, with a target distribution date of April 20, 2026Anaptys to manage the financial collaborations for Jemperli with GSK and...
March 27, 2026 09:00 ET | Source: Navigator Medicines INC

Navigator Medicines Advances NAV-240 into Phase 2a and NAV-242 into the Clinic, Supported by New Positive Data Presented at American Academy of Dermatology (AAD) Annual Meeting 2026

First Patient Dosed (FPD) in Phase 2a MAINSAIL Trial of NAV-240 in Hidradenitis Suppurativa (HS)Phase 1b Multiple Ascending Dose Study Demonstrates Favorable Profile for NAV-240 First Participant...
March 27, 2026 08:30 ET | Source: Jyong Biotech Ltd.

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2

New Taipei City, Taiwan, March 27, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development...
March 27, 2026 08:02 ET | Source: Hydrofarm Holdings Group, Inc.

Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2025 Results

Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2025 Results
March 27, 2026 08:00 ET | Source: PRF Technologies Ltd.

PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms

LayerBio’s OcuRing™-K program and broader ocular platform strengthen PRF’s healthcare growth strategy DeepSolar advances from acquisition to early commercial deployment TEL AVIV, Israel, March 27,...
March 27, 2026 08:00 ET | Source: Vor Biopharma

Vor Bio Announces $75 Million Private Placement with TCGX

BOSTON, March 27, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it has entered into a...